Citation: | LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo[5, 4-d]pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406 |
[1] |
Zhao PL,You WW,Duan AN.Research advances in antitumor activities of pyrimidine derivatives[J].Acta Pharm Sin(药学学报),2012,47(5):580-587.
|
[2] |
Burchat AF,Calderwood DJ,Friedman MM,et al.Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck-a selectivity insight[J].Bioorg Med Chem Lett,2002,12(12):1687-1690.
|
[3] |
Kim S, Schiff BA, Younes MN, et al. Treatment with NVP AEE788-a dual inhibitor of EFGR and VEGFR tyrosine kinase-inhibits anaplastic thyroid carcinoma growth[J].Clin Cancer Res,2003,9(16):6100S-6101S.
|
[4] |
Dai Y, Guo Y, Frey RR, et al. Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors[J].J Med Chem,2005,48(19):6066-6083.
|
[5] |
Miyazaki Y,Matsunaga S,Tang J,et al.Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors[J].Bioorg Med Chem Lett,2005,15(9):2203-2207.
|
[6] |
Miller DJ,Ravikumar K,Shen H,et al.Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibiton[J].J Med Chem,2002,45(1):90-98.
|
[7] |
Yildiz-Oren I,Yalcin I,Aki-Sener E,et al.Synthesis and structure-activity relationships of new antimicrobial active multi substituted benzazolederivatives[J].Eur J Med Chem,2004,39(3):291-298.
|
[8] |
Bauser M,Delapierre G,Hauswlad M,et al.Discovery and optimization of 2-aryl oxzaolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis[J].Bioorg Med Chem Lett,2004,14(8):1997-2000.
|
[9] |
Xu D,Sun LP,You QD.Facile synthesis of 2,5,7-trisubstituted oxazolo[5,4-d]pyrimidines via copper-catalyzed intramolecular C-O bond formation[J].Tetrahedron,2012,68(22):4248-4251.
|
[10] |
Polverino A,Coxon A,Starnes C,et al.AMG 706,an oral,multikinase inhibitor that selectively targets vascular endothelial growth factor,platelet-derived growth factor,and kit receptors,potently inhibits angiogenesis and induces regression in tumor xenografts[J].Cancer Res,2006,66(17):8715-8721.
|
[11] |
Mao ZW, Wan CP, Jiang Y, et al. Synthesis and anti-tumor activity in vitro of N-heterocycle substitutes benzofuranderivatives[J].J China Pharm Univ(中国药科大学学报),2015,46(1):58-61.
|
[12] |
Liang XW,Xu FM,Li XG,et al.VEGF signal system:the application of antiangiogenesis[J].Curr Med Chem,2014,21(7):894-910.
|
[1] | BAI Zhiwei, SHANG Feiyang, DAI Weiguo, HE Liqin. Synthesis and antitumor activities of NO-donating rhein derivatives[J]. Journal of China Pharmaceutical University, 2021, 52(1): 38-43. DOI: 10.11665/j.issn.1000-5048.20210105 |
[2] | LIN Jin, WANG Xu, WANG Jian, XU Xiuzhi, CHEN Yaohao, LI Zhulai. Synthesis and antitumor activities of 4-(N-aryl)amino-6-long chain alkoxy pteridine derivatives[J]. Journal of China Pharmaceutical University, 2018, 49(1): 64-71. DOI: 10.11665/j.issn.1000-5048.20180109 |
[3] | WANG Lu, YOU Qidong, JIANG Zhengyu. Design, synthesis and anti-tumor activity of novel 5-amino-2-(benzylthio)thiazole-4-carboxamide derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(1): 16-22. DOI: 10.11665/j.issn.1000-5048.20170103 |
[4] | QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305 |
[5] | MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204 |
[6] | HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105 |
[7] | LIANG Xiao-qing, SHI Chen-yang, WANG Ke, HE Xin, LIU Si-guo, HUANG Xiao-feng, LIU Yu. Anti-angiogenesis and anti-tumor activity of the fully human anti-VEGF165 monoclonal antibody obtained from the five-feature transgenic mice[J]. Journal of China Pharmaceutical University, 2012, 43(6): 560-566. |
[8] | HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119. |
[9] | REN Jie, CHENG Hong, WANG Wei, HU Kun. Synthesis and antitumor activity of novel chrysin derivatives[J]. Journal of China Pharmaceutical University, 2011, 42(3): 206-212. |
[10] | ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498. |